Prostate cancer Board decisions

The Board has granted service connection for residuals of prostate cancer, but remanded the issue of service connection for chest pain due to lack of substantial compliance with previous remand instructions.

The Board has remanded the cases due to VA's failure to obtain a specific Department of the Army letter regarding herbicide use in Korea from 1962 to 1970. The Veteran must be notified and given an opportunity to provide such records.

The Board has remanded multiple issues for further development, including service connection claims and exposure to ionizing radiation or chemical agents. The Veteran's PTSD claim is remanded due to inadequate VA opinions. His psychiatric condition, migraine headaches, prostate cancer, erectile dysfunction, urinary condition, sleep apnea, and hypogonadism claims are also remanded.

The Board has granted the Veteran's claims for service connection for bladder cancer, prostate cancer, and diabetes mellitus type II due to their presumptive association with service in Thailand under the PACT Act.

The Veteran's claim for a higher rating for prostate cancer residuals was granted with an effective date of August 22, 2012. The issue of a compensable rating for erectile dysfunction is remanded.

The Board denied the Veteran's claims for service connection for prostate cancer and interstitial pulmonary fibrosis, finding no evidence linking these conditions to his active-duty service or herbicide exposure.

The Veteran's service-connected disabilities do not meet the percentage requirements for a schedular TDIU rating from November 13, 2017 to May 31, 2022. The Board is remanding the issue of entitlement to an extraschedular TDIU rating for referral to the Director of Compensation Service.

The Veteran's claims for service connection for diabetes mellitus II, prostate disability (including prostate cancer), essential hypertension, ocular hypertension, kidney disease, right upper extremity peripheral neuropathy, left upper extremity peripheral neuropathy, right lower extremity peripheral neuropathy, and left lower extremity peripheral neuropathy have all been denied. The Board found that there is no evidence of in-service exposure to herbicide agents or any other event, injury, or disease related to the Veteran's claimed conditions.,The Board concluded that the Veteran did not meet the criteria for service connection as his claims are based on direct service connection and not on presumptive service connection due to exposure to herbicide agents.

The Veteran's prostate cancer, diabetes mellitus II, hypertension, erectile dysfunction, and peripheral neuropathy of the bilateral lower extremities are all granted as related to exposure to firefighting foam during service.

The Board has granted service connection for prostate cancer, finding that the Veteran was exposed to herbicide agents during his service on the USS America and that prostate cancer is related to this exposure.

The Board denied service connection for prostate cancer as there was no in-service exposure to herbicide agents, and the Veteran's claim is not supported by competent medical evidence of a nexus between his current condition and military service.

The Board has denied service connection for ischemic heart disease and prostate cancer, finding that the evidence does not support a link to service or any presumptive exposure to herbicide agents.

The Board has granted the Veteran's claims for service connection for prostate cancer and depression, with the latter being secondary to his service-connected prostate cancer.

The Veteran's death was due to liver failure, but the cause of his service-connected conditions is unclear. The Board finds that remand is necessary as the VA medical opinion did not adequately address the role of diabetes and other service-connected conditions in causing the Veteran's death.

The Veteran's service-connected disabilities did not preclude him from securing or following substantially gainful employment, and the Board denied his claim for TDIU.

The Board denied the Veteran's request for an effective date prior to July 31, 2019, for the grant of service connection for prostate cancer due to herbicide agent exposure. The earliest possible effective date is July 31, 2019, the date of receipt of his claim.

The Veteran's bilateral hearing loss is not related to service.,There is no current diagnosis of tinnitus in the Veteran.,Prostate cancer was not related to service, and there is no benefit of doubt to resolve in favor of the Veteran.,Neither foot disorder has been diagnosed as a current condition.,The Veteran's prostate cancer does not meet the criteria for an initial rating greater than 20 percent.

The Veteran's appeal for a higher rating of prostate cancer has been withdrawn, resulting in the dismissal of this issue.

The Veteran's prostate cancer is granted as presumptively related to his service in Southwest Asia. The right knee osteoarthritis claim was denied, but the Veteran received a 50% disability rating for his acquired psychiatric disorders starting October 1, 2019 and TDIU from December 18, 2019.

The Veteran's prostate cancer was not shown as chronic in service and did not manifest to a compensable degree within the applicable presumptive period. Continuity of symptomatology is not established, and the disability is not otherwise etiologically related to an in-service injury or disease.